Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 26 July 2011
Vol. 4, Issue 183, p. pc14
[DOI: 10.1126/scisignal.2002346]


Science Signaling Podcast: 26 July 2011

Sara A. Courtneidge1 and Annalisa M. VanHook2

1 Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
2 Web Editor, Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, NW, Washington, DC 20005, USA.

Abstract: This Podcast features a conversation with the senior author of a Research Article published in the 26 July 2011 issue of Science Signaling. Sara Courtneidge discusses her group’s screen to identify compounds that affect the formation of invadopodia, which are cellular projections that allow cancer cells to invade tissues. They identified a group of compounds that inhibited the cyclin-dependent kinase Cdk5 as inhibitors of invasion. Surprisingly, they also found that the chemotherapeutic agent paclitaxel increased the formation of invadopodia and promoted invasive behavior, suggesting that the use of paclitaxel might actually promote metastases in patients.

Citation: S. A. Courtneidge, A. M. VanHook, Science Signaling Podcast: 26 July 2011. Sci. Signal. 4, pc14 (2011).

Read the Full Text

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882